GMR Solutions Inc

Aktienanalyse zu GMR Solutions Inc (GMRS)

$10.730

-0.040 (-0.37%)Zum Schluss

Loading chart…
Hoch
10.830
Eröffnung
10.720
Volumengewichteter Durchschnittskurs
10.56
Volumen
356.86K
Marktkap.
—
Tief
10.130
Umsatz
3.77M
EV/EBITDA, TTM
7.26

GMR Solutions Inc. is a provider of emergency medical services and integrated providers of essential alternate-site, out-of-hospital care in the United States and mobile clinical practice groups globally. It maintains longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. Its emergent care services include rapid, clinically appropriate responses, lifesaving critical interventions and, when necessary, transport to the next site of care. Its non-emergent care services include scheduled and non-emergency patient care. Together with its professional pilots, mechanics, communications specialists and other operational support roles, it delivers comprehensive care across a range of time-sensitive patient conditions, from cardiac arrests, strokes and significant traumatic injuries to acute behavioral health episodes, toxic exposures, and emergent in-the-field newborn deliveries.

KI-Analyse of GMR Solutions Inc (GMRS)

Kaufen

GMR Solutions Inc. is a good buy right now due to its low forward P/E ratio of 0, indicating potential for significant upside, and a current price of $10.73, which is below the analyst price target of $16. The stock has shown a positive 5-day change of +7.30%, suggesting recent upward momentum. However, a key risk is the negative net income reported for Q2 2026, which was -28,278,000 USD, indicating financial instability that investors should monitor closely.

Bewertungskennzahlen

Das aktuelle erwartete KGV von GMR Solutions Inc (GMRS) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
6.28
Aktuelles EV/EBITDA
7.26
Überbewertet
7.74
Unterbewertet
4.82

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
0.11
Aktuelles P/S
0.09
Überbewertet
0.12
Unterbewertet
0.09

Whales, die GMRS halten

T

The Olayan Group

+ HältGMRS

+3.82%

3-Monats-Rendite

K

KKR & Co. Inc.

+ HältGMRS

-1.42%

3-Monats-Rendite

Event-Zeitleiste

2026-08-12 (ET)

17:00:00

GMR Reports Q2 Revenue of $1.49B, Exceeds Expectations

2026-07-08 (ET)

09:00:00

GMR Solutions Appoints New Board Members

2026-06-08 (ET)

11:50:00

Quantum Computing Company Quantinuum Prices IPO at $60

2026-06-01 (ET)

16:50:00

GMR Reports Q1 Revenue of $1.46B

2026-05-13 (ET)

13:40:00

GMR Solutions Prices 31.91M Shares at $15.00

News

GMRS FAQ – beantwortet von Alphio AI

GMR Solutions Inc. is a provider of emergency medical services and integrated providers of essential alternate-site, out-of-hospital care in the United States and mobile clinical practice groups globally. It maintains longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. Its emergent care services include rapid, clinically appropriate responses, lifesaving critical interventions and, when necessary, transport to the next site of care. Its non-emergent care services include scheduled and non-emergency patient care. Together with its professional pilots, mechanics, communications specialists and other operational support roles, it delivers comprehensive care across a range of time-sensitive patient conditions, from cardiac arrests, strokes and significant traumatic injuries to acute behavioral health episodes, toxic exposures, and emergent in-the-field newborn deliveries. It operates in the Healthcare sector.

GMR Solutions Inc. is a good buy right now due to its low forward P/E ratio of 0, indicating potential for significant upside, and a current price of $10.73, which is below the analyst price target of $16. The stock has shown a positive 5-day change of +7.30%, suggesting recent upward momentum. However, a key risk is the negative net income reported for Q2 2026, which was -28,278,000 USD, indicating financial instability that investors should monitor closely.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln